医学
非酒精性脂肪肝
肝移植
疾病
脂肪肝
药方
肥胖
肝病
重症监护医学
慢性肝病
儿科
移植
内科学
肝硬化
药理学
作者
Tania Mitsinikos,Paula Mrowczynski-Hernandez,Rohit Kohli
标识
DOI:10.1016/j.pcl.2021.07.013
摘要
Obesity has led fatty liver disease to become the most common chronic liver disease in children worldwide. Pediatric professional organizations have agreed that screening for fatty liver disease in children is the need of the hour. Once identified, prevention is key through appropriate dietary and activity prescriptions. Research continues to identify key pathways and genetic risk factors that predispose certain children to the more severe manifestations of this silent epidemic. We hope these novel observations lead to breakthrough treatments for these children that are severely impacted, such that they may no longer need liver transplantation as young adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI